Loading interface...

Etornext 600 mg Tablet ER

Manufactured byAlembic Ltd.
ContainsEtodolac
Description
Etornext 600 mg Tablet ER is a non-steroidal anti-inflammatory medicine used to relieve pain, stiffness, and swelling in different types of arthritis namely, osteoarthritis and rheumatoid arthritis. It works by preventing the release of certain chemical substances that cause pain and swelling in the body. Common side effects of Etornext 600 mg Tablet ER are nausea, vomiting, heartburn, stomach pain, loss of appetite, and diarrhoea. Do not use this medicine if you are previously allergic to it. Use it cautiously in individuals with liver and kidney problems. You can take Etornext 600 mg Tablet ER with food, milk, or an antacid to avoid stomach irritation. For the ease of remembering, take it at around the same time every day. Etornext 600 mg Tablet ER does not cure arthritis, but relieves symptoms and makes you feel better as long as you continue to take it.

Side effects

Major & minor side effects for Etornext 600 mg Tablet ER

  • Stomach pain
  • Diarrhoea
  • Blurred vision
  • Headache
  • Dizziness and Drowsiness
  • Skin rash
  • Excessive gas in stomach
  • Ringing or buzzing in the ears
  • Nausea and vomiting

Uses of Etornext 600 mg Tablet ER

What is it prescribed for?

  • Osteoarthritis
  • Rheumatoid Arthritis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    Etodolac tablet ER provides relief from pain within 2 to 4 hours of administration.
  • How long do the effects of this medicine last?
    The duration of action for the etodolac tablet ER is 6 to 12 hours. You may have to take your next dose if your pain continues.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended while treatment with Etornext 600 mg Tablet ER due to the risk of stomach bleeding.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported for Etornext 600 mg Tablet ER.
  • Can this medicine be taken during pregnancy?
    Etornext 600 mg Tablet ER is not recommended for use during pregnancy due to the risk of serious heart or kidney problems in the unborn baby. If required, it should only be used upon your doctor's recommendation.
  • Can this medicine be taken while breast-feeding?
    Etornext 600 mg Tablet ER is not recommended for use in breastfeeding women. An alternate medicine may be preferred, especially while nursing a newborn or preterm infant. If required, it should only be used upon your doctor's recommendation.

Allergy

Avoid taking Etornext 600 mg Tablet ER if you are previously allergic to it. Serious allergic reactions to this medicine are rare. However, seek immediate medical attention if you notice any symptoms of serious allergic reactions such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulties, etc.

Asthma

Patients with asthma may experience allergic reactions while taking Etornext 600 mg Tablet ER. Hence it is not recommended for use in patients with asthma, especially those who had experienced allergic reactions with the use of non-steroidal anti-inflammatory medicines.

Gastrointestinal disorders

Etornext 600 mg Tablet ER may cause stomach and intestinal bleeding and ulcers. Therefore it is not recommended for use in patients with gastrointestinal bleeding or perforation disorders since it may worsen the condition.

Heart surgery

Do not use Etornext 600 mg Tablet ER for relieving pain after heart surgery.
Warnings for special population

Pregnancy

Etornext 600 mg Tablet ER is not recommended for use during pregnancy due to the risk of serious heart or kidney problems in the unborn baby. If required, it should only be used upon your doctor's recommendation.

Breast-feeding

Etornext 600 mg Tablet ER is not recommended for use in breastfeeding women. An alternate medicine may be preferred, especially while nursing a newborn or preterm infant. If required, it should only be used upon your doctor's recommendation.
General warnings

Skin rash

Etornext 600 mg Tablet ER may cause serious skin allergies without any warnings. These events may be fatal in rare cases. Signs and symptoms like rashes, hives, fever, or other allergic symptoms should be reported to the doctor immediately. The treatment should be discontinued if these symptoms appear.

Elderly population

Etornext 600 mg Tablet ER should be used with caution in the elderly population due to an increase in the risk of undesired side effects. Close monitoring of kidney function and symptoms of bleeding is necessary while receiving this medicine.

Bleeding disorders

Etornext 600 mg Tablet ER may prolong the blood clotting time and therefore increase the risk of bleeding. Use it cautiously in patients with bleeding or clotting defects such as haemophilia, vitamin K deficiency, and hypoprothrombinemia.

Hypertension

Etornext 600 mg Tablet ER should be used with caution in patients with hypertension (high blood pressure) due to the increased risk of worsening of the condition. Monitor blood pressure levels while receiving this medicine.

Hyperkalemia

Etornext 600 mg Tablet ER may increase potassium levels in the blood. Potassium levels should be checked in patients receiving this medicine.

Driving or operating machinery

Etornext 600 mg Tablet ER may cause sleepiness, blurred vision or dizziness in some patients. Hence it is advised not to drive vehicles and operate heavy machinery after taking this medicine.

Missed Dose

Take the missed dose of Etornext 600 mg Tablet ER as soon as possible. If it is already time for your next scheduled dose, skip the missed dose.

Overdose

Seek emergency medical attention or contact your doctor in case of an overdose with Etornext 600 mg Tablet ER.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended while treatment with Etornext 600 mg Tablet ER due to the risk of stomach bleeding.
Interaction with Medicine

Ramipril

Warfarin

Ketorolac

Prednisolone

Disease interactions

Heart Disease

Long-term use of Etornext 600 mg Tablet ER may increase the risk of a heart attack in patients with pre-existing heart conditions or heart failure. It is not used for treating pain after coronary bypass surgery.

Impaired kidney function

Prolonged use of high doses of Etornext 600 mg Tablet ER may cause kidney problems, such as painful urination and protein or blood in the urine. Hence this medicine should be used cautiously in kidney impaired patients. Close monitoring of kidney function is necessary while receiving this medicine.

Impaired liver function

Patients with liver diseases should ask their pharmacist/doctor how Etornext 600 mg Tablet ER may affect their liver. Etornext 600 mg Tablet ER conversion to its active form may be reduced in patients with impaired liver function, which may lead to liver failure. A dosage reduction may be required in some patients.
Food interactions
Information not available.
Lab interactions
Information not available.
Etodolac extended-release tablets are used for relieving pain and swelling due to arthritis. It is available as etodolac 600, 500, and 400 mg. Take Etornext 600 mg Tablet ER with or after food. Never take more than the prescribed dose. Take this etodolac tab at the same time every day.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

May cause sleepiness

How it works
Etornext 600 mg Tablet ER stops the release of a chemical called prostaglandins, that increase pain and swelling. Thus, this medicine provides relief from your aches and makes you feel better.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Nonsteroidal anti-inflammatory agents

Schedule

Schedule H

Drugs, H., 2021. Etodolac: Medlineplus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 18 January 2021].

https://medlineplus.gov/druginfo/meds/a692015.html>

Dailymed.nlm.nih.gov. 2021. Dailymed - ETODOLAC Tablet, Extended Release. [online] Available at: < [Accessed 18 January 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=107ea9d7-80a9-41a4-b61e-168370127319>

Drugbank.ca. 2021. Etodolac | Drugbank Online. [online] Available at: < [Accessed 18 January 2021].

https://www.drugbank.ca/drugs/DB00749>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 18 January 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020584s004,006,007lbl.pdf>

Pubchem.ncbi.nlm.nih.gov. 2021. Etodolac. [online] Available at: < [Accessed 26 February 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Etodolac>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 26 Feb 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.